Aortic Stenting in Symptomatic Infrarenal Aortic Stenosis and Subtotal Aortic Occlusion

Abstract

Objective:

The aim of this study was to evaluate the long-term results of aortic stent placement in patients with infrarenal aortic occlusive disease.

Methods:

Between April 1996 and May 2014, 34 patients with symptomatic infrarenal atherosclerotic aortic stenosis or subtotal aortic occlusion underwent percutaneous angioplasty with primary aortic stent implantation. There were 21 patients with Fontaine stage of the peripheral arterial disease (PAD) II, 5 patients with stage III, and 8 patients with stage IV. One patient withdrew informed consent and was excluded from further analysis.

Results:

Patients (n = 34, mean age: 62 ± 12 years) were followed for a mean period of 81 months. There were 2 procedure-related access-related complications. Six patients died during follow-up from non-procedure-related causes. Eight patients had late recurrence of symptoms during follow-up. Only in 2 cases, symptomatic recurrences were due to aortic in-stent stenosis (77 and 132 months after the primary stent implantation). Additionally, these 2 patients required therapy for PAD progression distal to the aorta. Five patients required further surgical or endovascular reconstruction for PAD progression distal to the aorta. In another case, clinical treatment failure was due to the progression of atherosclerotic lesion in the perirenal, nonstented part of the abdominal aorta. The mean estimated primary patency rate was 185.6 months (95% confidence interval: 161.3-209.8).

Conclusion:

Endovascular stent implantation is a safe and long-term effective strategy for the treatment of infrarenal aortic occlusive disease. In our study, the recurrence of symptoms was observed mainly due to atherosclerosis progression by multilevel disease with associated infrainguinal occlusive lesions but not to aortic in-stent restenosis. The prognostic advantage for this relatively young cohort of patients can be the possibility to repeat a percutaneous procedure with less technical difficulties when compared to surgical revision.

Keywords

aortic stenting aortic infrarenal stenosis long term results

Get full access to this article

View all access options for this article.

References

Audet

Therasse

Oliva

. Infrarenal aortic stenosis: long term clinical and hemodynamic results of percutaneous transluminal angioplasty. Radiology. 1998;209(2):357–363.

Uberoi

Tsetis

. Standards for the endovascular management of aortic occlusive disease. Cardiovasc Intervent Radiol Soc Europe. 2007;30(5):814–819.

Hirsch

Haskal

Hertzer

. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006;113(11):e463–e654.

McPherson

Laing

Thomson

. Treatment of infrarenal aortic stenosis by stent placement: a 6 year experience. Australas Radiol. 1999;43(2):185–191.

Nyman

Uher

Lindh

Indblad

Ivancev

. Primary stenting in infrarenal aortic occlusive disease. CardioVasc Interv Radiol. 2000;23(2):97–108.

Rosset

Malikov

Magnan

. Endovascular treatment of occlusive lesions in the distal aorta: mid-term results in a series of 31 consecutive patients. Ann Vasc Surg. 2001;15(2):140–147.

Therasse

Cote

Oliva

Cusson

Wistaff

Nguyen

. Infrarenal aortic stenosis: value of stent placement after percutaneous transluminal angioplasty failure. Radiology. 2001;219(3):655–662.

Stoeckelhuber

Gellissen

Kueffer

. Primary endovascular stent placement for focal infrarenal aortic stenosis: long-term results. J Vasc Interv Radiol. 2006;17(7):1105–1109.

Schedel

Wissqott

Rademaker

Steinkamp

. Primary stent placement for infrarenal aortic stenosis: immediate and midterm results. J Vasc Interv Radiol. 2004;15(4):353–359.

10.

Simons

PCG

Nawijn

Bruijninckx

CMA

Knippenberg

deVries

VanOverhagen

. Long-term results of primary stent placement to treat infrarenal aortic stenosis. Eur J Vasc Endovasc Surg. 2006;32(6):627–633.

11.

Ruppert

Wirth

Rieger

Kueffer

Steckmeier

Stoeckelhuber

. Long-term results after primary stenting of distal aortic stenosis. J Endovasc Ther. 2006;13(2):229–236.

12.

Klonaris

Katsargyris

Tsekouras

Alexandrou

Giannopoulos

Bastounis

. Primary stenting for aortic lesions: from single stenoses to total aortoiliac occlusions. J Vasc Surg. 2008;47(2):310–317.

13.

Schwindt

Panuccio

Donas

Ferretto

Austermann

Torsello

. Endovascular treatment as first line approach for infrarenal aortic occlusive disease. J Vasc Surg. 2011;53(6):1550–1556.

14.

Tapping

Ahmed

Scott

. Primary infrarenal aortic stenting with or without iliac stenting for isolated and aortoiliac stenoses: single-centre experience with long-term follow-up. Cardiovasc Intervent Radiol. 2013;36(1):62–68.

15.

Sohgawa

Sakai

Nago

. Mid-term results of endovascular treatment for infrarenal aortic stenosis and occlusion. Osaka Citi Med J. 2015;61(1):1–8.

16.

Monastiriotis

Loh

Tassiopoulos

Labropoulos

. Clinical characteristics and outcome of isolated infrarenal aortic stenosis in young patients. J Vasc Surg. 2018;67(4):1143–1149.

17.

Norgen

Hiatt

Dormandy

Nehler

Harris

Fowkes

. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45(1):S5–S67.

18.

Grimme

FAB

Goverde

PCJM

Verbruggen

PJEM

Zeebregt

Reijnen

MMPJ

. First results of the Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) technique for aortoiliac occlusive disease. Eur J Vasc Endovasc Surg. 2015;50(5):638–647.

19.

Brewster

. Clinical and anatomical considerations for surgery in aortoiliac disease and results of surgical treatment. Circulation. 1991;83(2 Suppl):I42–I52.

20.

Vallabhaneni

Bjorses

Malina

Dias

Sonesson

Ivancev

. Endovascular management of isolated aortic occlusive disease is safe and effective in selected patients. Eur J Vasc Endovasc Surg. 2005;30(3):307–310.

21.

Berger

Sorensen

Konrad

. Aortic rupture: a complication of transluminal angioplasty. Am J Roentgenol. 1986;146(2):373–374.

22.

Cutry

Whitley

Patterson

. Midaortic pseudoaneurysm complicating extensive endovascular stenting of aortic disease. J Vasc Surg. 1997;26(6):958–962.

23.

Diethrich

. Endovascular treatment of abdominal aortic occlusive disease: the impact of stents and intravascular ultrasound imaging. Eur J Vasc Surg. 1993;7(3):228–236.

24.

George

Singh

Ram

. An endovascular filter to prevent embolization during aortic stenting. J Vasc Surg. 2016;63(2):548–551.

25.

Feugier

Toursarkissian

Chevalier

Favre

. Endovascular treatment of isolated atherosclerotic stenosis of the infrarenal abdominal aorta: long-term outcome. Ann Vasc Surg. 2003;17(4):375–385.

26.

D’Othee

Haulon

Mounier-Vehier

Beregi

Jabourek

Willoteaux

. Percutaneous endovascular treatment for stenosis and occlusions of infra-renal aorta and aortoiliac bifurcation midterm results. Eur J Vasc Endovasc Surg. 2002;24(6):516–523.